Alamar Biosciences, Inc. ALMR

Set alert

Price alert · ALMR

All alert types
29.51 USD +0.57 +1.97%

As of Nov 3, 1:00 PM ET

Bid
29.45 × 2
Ask
29.56 × 2
29.18 Day range 30.27
18.85 52-week range 39.61
YTD
+34.14%
1 year
+34.14%
Open
29.18
Prev close
28.94
Mkt cap
2.04B
Vol
250.64K
Avg vol
557.51K
EPS
-1.20
P/E
0.00
Div yield
0.00%
More statistics
Low
29.18
High
30.27
Forward P/E
-64.05
Beta
0.00
Short ratio
3.53
Inst. own
57.21%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
30.65
200-d avg
26.93
1y target
35.40

MAX chart

Chart tools
Interval

Events in this range
  • May 8, 2026Earnings: -1.74; estimate -1.71; surprise -1.75%
  • May 12, 2026Rating: Stifel · — → Buy
  • May 12, 2026Rating: JP Morgan · — → Overweight
  • May 12, 2026Rating: TD Cowen · — → Buy
  • May 12, 2026Rating: Leerink Partners · — → Outperform
  • Aug 10, 2026Earnings: -0.22; estimate -0.30787; surprise 28.54%
  • Aug 11, 2026Rating: JP Morgan · Overweight → Overweight
  • Aug 11, 2026Rating: Stifel · Buy → Buy
  • Nov 3, 2026Earnings: —; estimate -0.2015; surprise —%
Signals (47)
NameDateAgo
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 23, 20261 week ago
SMA: BearishOct 22, 20261 week ago
SMA: BullishOct 21, 20261 week ago
MACD: Buy SignalOct 21, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago
SMA: BearishOct 7, 20263 weeks ago
MACD: Sell SignalOct 7, 20263 weeks ago
SMA: BearishOct 6, 20264 weeks ago
SMA: BullishOct 2, 20261 month ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 30, 20261 month ago
SMA: BearishSep 29, 20261 month ago
MACD: Buy SignalSep 18, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BullishSep 16, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishAug 27, 20262 months ago

Newest 20 of 47.

Analyst view

Price target (mean) 35.40 +20.0% upside
Target (low)
31.00
Target (mean)
35.40
Target (high)
45.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ALMR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.18688-0.26 – -0.100.000.0%30.19M0.0%4
Next quarter-0.18492-0.24 – -0.130.000.0%32.88M0.0%4
Current year-1.10-1.31 – -0.860.000.0%118.58M0.0%4
Next year-0.4518-0.90 – -0.12-1.10+59.0%165.71M+39.8%4

Upgrades and downgrades

The latest rating changes

ALMR analyst upgrades and downgrades
DateFirmActionFromTo
Aug 11, 2026StifelMaintainedBuyBuy
Aug 11, 2026JP MorganMaintainedOverweightOverweight
May 12, 2026Leerink PartnersInitiated—Outperform
May 12, 2026TD CowenInitiated—Buy
May 12, 2026JP MorganInitiated—Overweight
May 12, 2026StifelInitiated—Buy